NEW YORK (GenomeWeb) – Curetis has received CE-IVD marking for its multiplex PCR-based assay for severe intra-abdominal infections. The firm plans to launch the test at upcoming conferences in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.